Furthermore, USP4 targeted on TGFβ-activated kinase 1 (TAK1) to downregulate NF-κB activation, which was highly expressed in CD4+ T cell from rheumatic heart disease (Wang et al., 2013). This evidence concerns the gene CD4 and rheumatic heart disease.